该高血压患儿是否患有继发性高血压?理性临床检查系统综述
本系统综述纳入30项研究,其中23项(N=4210例儿童和青少年)进行Meta分析,旨在评估病史、体格检查和24小时动态血压监测在区分原发性与继发性高血压中的效用。在初级保健或学校筛查诊所,继发性高血压患病率为9.0%(95%CI,4.5%-15.0%);在亚专科诊所则为44%(95%CI,36%-53%)。继发性高血压家族史、年龄≤6岁、体重≤第10百分位、早产史、微量白蛋白尿、血清尿酸≤5.5 mg/dL以及动态血压监测中白天舒张压负荷和夜间收缩压负荷增高与继发性高血压可能性升高相关;无症状表现、肥胖和任何高血压家族史与可能性降低相关。没有任何单个症状或体征能明确区分继发性与原发性高血压。
要点
- 继发性高血压家族史(LR 4.7)、体重≤第10百分位(LR 4.5)、微量白蛋白尿(LR 13)与继发性高血压可能性升高相关。
- 无症状表现(LR 0.19-0.36)、肥胖(LR 0.34)、任何高血压家族史(LR 0.42)与继发性高血压可能性降低相关。
- 高血压分期、头痛和左心室肥厚不能区分继发性和原发性高血压。
核心结论
- 继发性高血压家族史、年龄较小、体重较低以及24小时动态血压监测中血压负荷增高与继发性高血压可能性较高相关。
- 没有任何单个症状或体征能明确区分继发性高血压与原发性高血压。
研究设计与样本
- 系统综述,检索MEDLINE、PubMed Central、Embase、Web of Science和Cochrane Library自建库至2022年1月,无语言限制。
- 共筛选3254条独特标题和摘要,30项研究符合Meta分析纳入标准,其中23项(N=4210例儿童和青少年)用于Meta分析合并。
- 采用随机效应模型计算敏感度、特异度和似然比(LR),使用QUADAS工具评估偏倚风险。
主要发现
- 在初级保健诊所或学校筛查诊所的3项研究中,继发性高血压患病率为9.0%(95%CI,4.5%-15.0%);在亚专科诊所的20项研究中为44%(95%CI,36%-53%)。
- 与继发性高血压关联最强的人口学特征:继发性高血压家族史(敏感度0.46;特异度0.90;LR 4.7 [95%CI,2.9-7.6])、体重≤同年龄同性别第10百分位(敏感度0.27;特异度0.94;LR 4.5 [95%CI,1.2-18])、早产史(敏感度范围0.17-0.33;特异度范围0.86-0.94;LR范围2.3-2.8)、年龄≤6岁(敏感度范围0.25-0.36;特异度范围0.86-0.88;LR范围2.2-2.6)。
- 与继发性高血压关联最强的实验室检查:微量白蛋白尿(敏感度0.13;特异度0.99;LR 13 [95%CI,3.1-53])、血清尿酸浓度≤5.5 mg/dL(敏感度范围0.70-0.73;特异度范围0.65-0.89;LR范围2.1-6.3)。
- 24小时动态血压监测中白天舒张压负荷增高合并夜间收缩压负荷增高与继发性高血压相关(敏感度0.40;特异度0.82;LR 4.8 [95%CI,1.2-20])。
- 与继发性高血压可能性降低相关的特征:无症状表现(LR范围0.19-0.36)、肥胖(LR 0.34 [95%CI,0.13-0.90])、任何高血压家族史(LR 0.42 [95%CI,0.30-0.57]);高血压分期、头痛和左心室肥厚不能区分继发性和原发性高血压。
关键数值与推荐
- 继发性高血压家族史:LR 4.7(95%CI,2.9-7.6)。
- 体重≤同年龄同性别第10百分位:LR 4.5(95%CI,1.2-18)。
- 微量白蛋白尿:LR 13(95%CI,3.1-53)。
- 血清尿酸浓度≤5.5 mg/dL:LR范围2.1-6.3。
- 白天舒张压负荷合并夜间收缩压负荷增高:LR 4.8(95%CI,1.2-20);无症状表现LR范围0.19-0.36,肥胖LR 0.34(95%CI,0.13-0.90),任何高血压家族史LR 0.42(95%CI,0.30-0.57)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Guidelines recommend that all children and adolescents with hypertension undergo evaluation for secondary causes. Identifying clinical factors associated with secondary hypertension may decrease unnecessary testing for those with primary hypertension. OBJECTIVE: To determine the utility of the clinical history, physical examination, and 24-hour ambulatory blood pressure monitoring for differentiating primary hypertension from secondary hypertension in children and adolescents (aged ≤21 years). DATA SOURCES AND STUDY SELECTION: The databases of MEDLINE, PubMed Central, Embase, Web of Science, and Cochrane Library were searched from inception to January 2022 without language limits. Two authors identified studies describing clinical characteristics in children and adolescents with primary and secondary hypertension. DATA EXTRACTION AND SYNTHESIS: For each clinical finding in each study, a 2 × 2 table was created that included the number of patients with and without the finding who had primary vs secondary hypertension. Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. MAIN OUTCOMES AND MEASURES: Random-effects modeling was used to calculate sensitivity, specificity, and likelihood ratios (LRs). RESULTS: Of 3254 unique titles and abstracts screened, 30 studies met inclusion criteria for the meta-analysis and 23 (N = 4210 children and adolescents) were used for pooling in the meta-analysis. In the 3 studies conducted at primary care clinics or school-based screening clinics, the prevalence of secondary hypertension was 9.0% (95% CI, 4.5%-15.0%). In the 20 studies conducted at subspecialty clinics, the prevalence of secondary hypertension was 44% (95% CI, 36%-53%). The demographic findings most strongly associated with secondary hypertension were family history of secondary hypertension (sensitivity, 0.46; specificity, 0.90; LR, 4.7 [95% CI, 2.9-7.6]), weight in the 10th percentile or lower for age and sex (sensitivity, 0.27; specificity, 0.94; LR, 4.5 [95% CI, 1.2-18]), history of prematurity (sensitivity range, 0.17-0.33; specificity range, 0.86-0.94; LR range, 2.3-2.8), and age of 6 years or younger (sensitivity range, 0.25-0.36; specificity range, 0.86-0.88; LR range, 2.2-2.6). Laboratory studies most associated with secondary hypertension were microalbuminuria (sensitivity, 0.13; specificity, 0.99; LR, 13 [95% CI, 3.1-53]) and serum uric acid concentration of 5.5 mg/dL or lower (sensitivity range, 0.70-0.73; specificity range, 0.65-0.89; LR range, 2.1-6.3). Increased daytime diastolic blood pressure load combined with increased nocturnal systolic blood pressure load on 24-hour ambulatory blood pressure monitoring was associated with secondary hypertension (sensitivity, 0.40; specificity, 0.82; LR, 4.8 [95% CI, 1.2-20]). Findings associated with a decreased likelihood of secondary hypertension were asymptomatic presentation (LR range, 0.19-0.36), obesity (LR, 0.34 [95% CI, 0.13-0.90]), and family history of any hypertension (LR, 0.42 [95% CI, 0.30-0.57]). Hypertension stage, headache, and left ventricular hypertrophy did not distinguish secondary from primary hypertension. CONCLUSIONS AND RELEVANCE: Family history of secondary hypertension, younger age, lower body weight, and increased blood pressure load using 24-hour ambulatory blood pressure monitoring were associated with a higher likelihood of secondary hypertension. No individual sign or symptom definitively differentiates secondary hypertension from primary hypertension.
引用
- Nugent JT, Jiang K, Funaro MC, et al. Does This Child With High Blood Pressure Have Secondary Hypertension?: The Rational Clinical Examination Systematic Review. JAMA. 2023. PMID: 36976276. doi:10.1001/jama.2023.3184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。